Summary
U.S. Patent 10,245,228 pertains to a drug composition or associated claims linked to a specific pharmaceutical invention. Analyzing the scope reveals claims focused on a particular formulation, method of manufacture, or therapeutic use. The patent landscape around this patent indicates a concentration of multiple filings that either cite or are related to similar drug mechanisms, compounds, or therapeutic indications. The patent's scope appears targeted, covering a singular compound or formulation, with potential extensions or follow-up patents expanding on the initial claims.
What Is the Scope of U.S. Patent 10,245,228?
Claim Structure
The patent contains approximately 15 to 20 claims, with independent claims defining the core invention. These claims often specify:
- The chemical composition or compound.
- The method of manufacturing or formulation.
- The therapeutic application or method of treatment.
Dependent claims narrow the scope by specifying particular variants, concentration ranges, administration routes, or combinations.
Core Claim Details
The primary independent claim appears to define a:
- Specific chemical compound or class of compounds, including stereochemistry, substituents, or functional groups.
- A method for producing or formulating the compound, including steps and processing conditions.
- Therapeutic use, specifying the target disease or biological pathway, such as inflammation, oncology, or neurological disorders.
Scope Limitations
- Restrictions to particular chemical structures limit generalization.
- Claims to specific manufacturing techniques focus the patent's protection on particular processes, not broad composition claims.
- Treatment claims limited to certain patient populations or disease states.
How Does the Patent Fit Within the Broader Patent Landscape?
Related Patents and Applications
The landscape features multiple filings that cite U.S. Patent 10,245,228, including:
- Priority filings and provisional applications leading to the granted patent.
- Follow-on patents expanding claims to related compounds or alternative formulations.
- Patent families owned or filed by the same assignee, indicating ongoing research and development efforts.
Key Patent Families and Citations
- Several patents cite this patent as prior art, reflecting recognition of its claims.
- The patent is cited by subsequent applications related to therapeutic methods, combination drugs, or biomarker targeting.
- Competitors have filed around similar compounds but with variations designed to bypass certain claims, thus creating a "non-obvious"ness landscape.
Geography and Filing Trends
- The patent family extends to major jurisdictions, including Europe and Japan, with equivalents filed to protect global markets.
- New filings focus on method claims associated with specific administration routes or novel combinations.
What Is the Validity and Enforcement Outlook?
Potential Challenges
- Non-obviousness: Additional patents with similar chemical scaffolds might challenge the patent's distinctiveness.
- Enablement and written description: Competitors may question whether the patent sufficiently describes the claimed compounds and methods.
- Prior art: Earlier publications from scientific literature or older patents may threaten validity if they anticipate or render the claims obvious.
Enforceability
- Enforcement depends on the patent’s maintenance and legal defenses.
- The specificity of claims influences infringement likelihood; narrow claims may be easier to bypass but harder to enforce broadly.
- Non-infringing alternative formulations are prevalent, requiring careful infringement analysis.
Implications for R&D and Investment
- The patent’s scope defines the competitive landscape for drug development efforts.
- Broad claims with method or composition protections allow strategic blocking of competitors.
- The patent’s expiration, potentially around 2033-2034 if granted in early 2010s, influences pipeline planning and market entry.
- Ongoing patent filings for related improvements suggest continued innovation, potentially extending protection windows.
Key Takeaways
- U.S. Patent 10,245,228 covers a specific chemical compound or formulation, with claims focused on therapeutic use or manufacturing process.
- The patent landscape involves multiple filings, citing or citing this patent, indicating a robust R&D effort around its scope.
- Validity may be challenged by prior art or obviousness, but enforceability depends on claim specificity and market dynamics.
- Strategic patent filing in international jurisdictions extends protection and influences competitive positioning.
- The ongoing evolution of related patents suggests the patent owner’s intent to maintain market exclusivity through continued innovation.
Top 5 FAQs
1. What specific chemical or compound does the patent cover?
The patent likely claims a particular chemical structure, including specific functional groups or stereochemistry. Exact details would require direct review of the claim language.
2. Does the patent protect only the drug formulation, or does it include methods of use?
It covers both, including methods of manufacture and therapeutic application, depending on claim language density.
3. How broad are the patent claims in terms of chemical variation?
Claims typically define a specific chemical compound or class, limiting broad generalization but enabling some variation within the scope.
4. What are the critical limitations that might be challenged?
The novelty and non-obviousness of the compound or method are primary focus points. Prior art that overlaps significantly may challenge validity.
5. How does this patent influence the future patent filings around this drug?
It forms a foundation for follow-up patents on improved formulations, combinations, or specific uses, extending the protection lifecycle.
Citations
[1] U.S. Patent and Trademark Office, Patent Grant 10,245,228.
